A phase III clinical trial, HEALOS, is currently recruiting. The trial title is “Efficacy and Safety of AM-111 in the Treatment of Acute Inner Ear Hearing Loss (HEALOS)”.
Do you see patients with sudden deafness?
Are you not satisfied with current treatment options?
If so, you may consider referring your patient for further diagnosis and treatment to a participating study centre.
This trial includes treatment-naïve patients with idiopathic sensorineural hearing loss (ISSNHL) with onset within 72 hours prior to study treatment.
The HEALOS trial is currently open for recruitment in selected hospitals and clinics in Europe and Asia according to our map, to evaluate a new promising treatment option (AM-111) for patients with severe to profound idiopathic sudden sensorineural hearing loss.